Literature DB >> 25444511

Knockdown of prohibitin expression promotes glucose metabolism in eutopic endometrial stromal cells from women with endometriosis.

Xiaochen Qi1, Yanxin Zhang2, Hui Ji3, Xiadi Wu4, Fuxin Wang5, Manxin Xie6, Li Shu4, Shiwen Jiang7, Yundong Mao8, Yugui Cui4, Jiayin Liu4.   

Abstract

In this in-vitro study, the effect of prohibitin (PHB) on glucose metabolism in eutopic endometrial stromal cells from women with endometriosis was investigated. Endometrial stromal cells were isolated from endometrium in women with endometriosis, in women without endometriosis, or from endometrioma tissues. Glucose metabolic phenotype of stromal cells were examined in vitro. Quantitative polymerase chain reaction was used to measure the mRNA expression of glycolysis-related genes. Glucose consumption and lactate production were examined after knockdown of PHB expression in women with endometriosis with siRNA. In endometrioma tissue, significantly increased glucose consumption, lactate production and aberrant expression of glycolysis-related enzymes were found in women with endometriosis compared with women who do not have endometriosis (P < 0.05 versus P < 0.001). In women with endometriosis, PHB mRNA and protein were under-expressed in endometrioma tissue; in women without endometriosis, PHB mRNA and protein were over-expressed. Knockdown of PHB expression in women with endometriosis increased glucose consumption, although it had no effect on lactate production. This study suggests that aberrant expression of glycolysis-related enzymes in endometrioma tissue is associated with enhanced glycolytic metabolism. The malignant-like feature may be partially caused by low-expression of PHB gene in endometriotic stromal cells.
Copyright © 2014 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  endometriosis; glucose metabolism; glycolysis; prohibitin

Mesh:

Substances:

Year:  2014        PMID: 25444511     DOI: 10.1016/j.rbmo.2014.09.004

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  3 in total

1.  Targeting stearoyl-CoA desaturase 1 to repress endometrial cancer progression.

Authors:  Weihua Li; Huimin Bai; Shiping Liu; Dongyan Cao; Hongying Wu; Keng Shen; Yanhong Tai; Jiaxin Yang
Journal:  Oncotarget       Date:  2018-01-24

2.  HSF1 promotes endometriosis development and glycolysis by up-regulating PFKFB3 expression.

Authors:  Yixin Wang; Jing Xiu; Tingting Yang; Chune Ren; Zhenhai Yu
Journal:  Reprod Biol Endocrinol       Date:  2021-06-09       Impact factor: 5.211

Review 3.  Nonhormonal therapy for endometriosis based on energy metabolism regulation.

Authors:  Hiroshi Kobayashi; Hiroshi Shigetomi; Shogo Imanaka
Journal:  Reprod Fertil       Date:  2021-11-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.